Detail akcie H&R Br online

Business Summary: H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Financial Summary: BRIEF: For the nine months ended 30 September 2024, H&R GmbH & Co KgaA revenues decreased 2% to EUR1.01B. Net income decreased 44% to EUR6.3M. Revenues reflect Chemica Pharmaceutical Raw Materials Refining segment decrease of 2% to EUR621.8M, Chemical Pharmaceutical Raw Materials Sales segment decrease of 3% to EUR370.2M, Rest of Europe segment decrease of 9% to EUR141.9M, Rest of world. segment decrease of 2% to EUR334.5M.